Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
George A. Scangos currently holds 24,000 shares of Vir Biotechnology, Inc. (VIR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, George A. Scangos has been a net seller of VIR stock. They have purchased $155.2K and sold $59.2M worth of shares.
George A. Scangos's most recent insider trade was on Jun 5, 2024, when they sold 24,000 shares at $0.00 per share.
George A. Scangos serves as Executive at Vir Biotechnology, Inc. (VIR). They have executed 1926 insider transactions totaling $59.4M over their tenure at the company.
George A. Scangos holds the position of Executive at Vir Biotechnology, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
George A. Scangos has shown a selling trading pattern, with $155.2K in total purchases and $59.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by George A. Scangos was on Feb 18, 2022, when they sold $543.3K worth of VIR shares. This transaction involved 17,726 shares at $30.65 per share.
George A. Scangos currently owns 24,000 shares of Vir Biotechnology, Inc. (VIR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of George A. Scangos's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. George A. Scangos has 1926 Form 4 filings on record as an insider at Vir Biotechnology, Inc..
Set alerts for George A. Scangos and 40,000+ other insiders.